Pharmena S.A. (WSE:PHR)
Poland · Delayed Price · Currency is PLN 3.400
-0.010 (-0.29%)
May 21, 2026, 5:00 PM CET
Pharmena Company Description
Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally.
The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis.
It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial.
Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.
Pharmena S.A.
| Country | Poland |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Konrad Palka |
Contact Details
Address: Gdanska 47/49 Lódz Poland | |
| Phone | 48 42 280 77 07 |
Stock Details
| Ticker Symbol | PHR |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLPHRMN00011 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Konrad Palka | President of Management Board, Chief Executive Officer and President |
| Marzena Wieczorkowska | Vice President of the Management Board and VP of Research and Development |